You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

MIGLITOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Miglitol, and what generic alternatives are available?

Miglitol is a drug marketed by Westminster Pharms and is included in one NDA.

The generic ingredient in MIGLITOL is miglitol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the miglitol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Miglitol

A generic version of MIGLITOL was approved as miglitol by WESTMINSTER PHARMS on February 24th, 2015.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MIGLITOL?
  • What are the global sales for MIGLITOL?
  • What is Average Wholesale Price for MIGLITOL?
Drug patent expirations by year for MIGLITOL
Drug Prices for MIGLITOL

See drug prices for MIGLITOL

Recent Clinical Trials for MIGLITOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of ZambiaPhase 3
University Teaching Hospital, Lusaka, ZambiaPhase 3
Canadian Network for Observational Drug Effect Studies, CNODES

See all MIGLITOL clinical trials

Pharmacology for MIGLITOL

US Patents and Regulatory Information for MIGLITOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Westminster Pharms MIGLITOL miglitol TABLET;ORAL 203965-001 Feb 24, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Westminster Pharms MIGLITOL miglitol TABLET;ORAL 203965-002 Feb 24, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Westminster Pharms MIGLITOL miglitol TABLET;ORAL 203965-003 Feb 24, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.